Bridgeway Capital Management’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,308
| Closed | -$24.8K | – | 1233 |
|
|
2025
Q1 | $24.8K | Sell |
4,308
-1,325
| -24% | -$7.64K | ﹤0.01% | 1148 |
|
|
2024
Q4 | $52.1K | Sell |
5,633
-250
| -4% | -$2.31K | ﹤0.01% | 1154 |
|
|
2024
Q3 | $96.7K | Hold |
5,883
| – | – | ﹤0.01% | 1164 |
|
|
2024
Q2 | $112K | Hold |
5,883
| – | – | ﹤0.01% | 1153 |
|
|
2024
Q1 | $157K | Sell |
5,883
-2,000
| -25% | -$53.5K | ﹤0.01% | 1144 |
|
|
2023
Q4 | $108K | Hold |
7,883
| – | – | ﹤0.01% | 1229 |
|
|
2023
Q3 | $122K | Hold |
7,883
| – | – | ﹤0.01% | 1190 |
|
|
2023
Q2 | $170K | Hold |
7,883
| – | – | ﹤0.01% | 1170 |
|
|
2023
Q1 | $140K | Sell |
7,883
-4,167
| -35% | -$74K | ﹤0.01% | 1170 |
|
|
2022
Q4 | $204K | Buy |
12,050
+7,492
| +164% | +$127K | 0.01% | 1083 |
|
|
2022
Q3 | $150K | Sell |
4,558
-5,834
| -56% | -$192K | ﹤0.01% | 1196 |
|
|
2022
Q2 | $586K | Sell |
10,392
-833
| -7% | -$47K | 0.01% | 846 |
|
|
2022
Q1 | $655K | Buy |
11,225
+4,167
| +59% | +$243K | 0.01% | 876 |
|
|
2021
Q4 | $508K | Sell |
7,058
-2,500
| -26% | -$180K | 0.01% | 980 |
|
|
2021
Q3 | $773K | Buy |
9,558
+391
| +4% | +$31.6K | 0.01% | 904 |
|
|
2021
Q2 | $883K | Buy |
+9,167
| New | +$883K | 0.02% | 904 |
|